fore, it is likely that ␣-syn inclusions can impair cellular function by obstructing normal cellular trafficking and disrupting cell morphology, as well as trapping other cellular components, which can eventually lead to cell death.
Although the preponderance of evidence supports the idea that ␣-syn toxicity is linked to the formation of pathological inclusions, Lansbury and colleagues are strong advocates that protofibrils may be toxic (Goldberg (Hochstrasser, 1996) . The 26S proteasome is composed of two major components, the 19S cap and the 20S core protein complexes. The 20S core complex is basically a cylinder with a narrow opening at both ends, and the proteolytic activities reside within the hollow transversal cavity. The 20S complex by itself is active, but only small peptides and unfolded elongated proteins can enter the openings (see Figure 2B) . The 26S proteasome machinery consists of two 19S complexes that sit at both ends of the 20S barrel. The 19Scomplex is involved in the recognition of polyubiquitinated substrates, assists in the unfolding of the target protein for entry into the opening of the cylinder, and cleaves off the polyubiquitinated chain from the substrate (see Figure 2C) .
Recognition of the substrates by the proteasome is enhanced by longer polyubiquitin chains, and tetraubiquitin appears to be the minimum signal for efficient gle factor that is responsible for juvenile (Ͻ21 years) and early (Ͻ45 years)-onset parkinsonism, and mutations in this gene are responsible for ‫%05ف‬ of individuals with Regulation of Ubiquitination and Substrate Selectivity this disorder if they have a family history. The parkin gene was initially identified as the genetic defect responUbiquitin is an abundant 76 amino acid polypeptide that can be covalently conjugated to specific proteins by the sible for a disease entity known as autosomal recessive juvenile parkinsonism (AR-JP) in a Japanese population formation of an isopeptide bond between its carboxyl terminus and the amino group of a lysine residue of the (Kitada et al., 1998). In most cases, parkinsonism linked to parkin is associated with the loss of function of both target proteins. This process requires several enzymes that are needed to ensure specificity and to activate the alleles. However, in a small subset of patients, methodical analysis including sequencing of the entire coding ubiquitin moiety (see Figure 2A ). The first step involves the ubiquitin-activating enzyme (E1), which forms a thiol region, the promoter region, and intron/exon boundaries, and assessment of exonic deletion and duplicaester linkage between a cysteine residue and the carboxy-terminal glycine in ubiquitin in an ATP-dependent tion revealed a genetic alteration on only one allele (West et al., 2002 ). Therefore, it is possible that parkin haplomanner (Hochstrasser, 1996) . This activated ubiquitin moiety is then transferred to one of several possible insufficiency can lead to disease, but it is difficult to completely exclude the possibility that some other mucarrier proteins (E2s) via the formation of another thiol ester linkage. Finally, ubiquitin is specifically transferred tation, perhaps within the introns, is present on the second allele. So far, parkin mutations in the parkin gene to the substrate with the assistance of an E3 ligase or ligase complex (Hochstrasser, 1996) . include: (1) point mutations, either nonsense or missense, (2) deletions of one or several exons that can Several internal lysine residues (with Lys 48 being the predominant residue used) within ubiquitin can further result in premature termination of translation or in-frame deletions, which are predicted to produce shorter probe used as substrates to create polyubiquitinated Figure 3A) . Parkin has been shown to be able to serve as an E3 ligase through it interaction with the E2 ubiquitin-carrier proteins Ubc H7 (Shimura Figure 3C) . Interestingly, the Ser18Tyr polymorphism in UCHL-1 displays a dramatic which may be unable to unfold and degrade these stable aggregates (see Figure 3E ). This hypothesis is consisreduction of ubiquityl ligase activity in vitro, with no changes in the hydrolase activity (Liu et al., 2002) . The tent with a reduction in functional proteasome activity in the SN of PD patients (McNaught and Jenner, 2001) Ile93Met substitution also results in reduced (50%) li-
